Subclonal TP53 and KRAS variants combined with poor treatment response identify ultrahigh-risk pediatric patients with T-ALL
Sign Up to like & getrecommendations! Published in 2025 at "Blood Advances"
DOI: 10.1182/bloodadvances.2024014209
Abstract: Key Points • In a case-control study, TP53/KRAS variants were enriched in relapsing patients at initial diagnosis compared with nonrelapsing patients.• In unselected patients, TP53/KRAS variants combined with poor treatment response identified a subgroup with… read more here.
Keywords: kras variants; treatment response; combined poor; variants combined ... See more keywords
The prevalence of common KRAS variants and associated outcomes in patients with metastatic colorectal cancer (mCRC).
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2022.40.4_suppl.173
Abstract: 173 Background: KRAS is the most common driver oncogene in mCRC. Comprehensive analysis of KRAS variants prevalence and the relationship between variants and outcomes are lacking. Herein, we aimed to examine the impact of KRAS… read more here.
Keywords: outcomes patients; novo metastatic; kras variants; prevalence ... See more keywords
Identification of Codon 146 KRAS Variants in Isolated Epidermal Nevus and Multiple Lesions in Oculoectodermal Syndrome: Confirmation of the Phenotypic Continuum of Mosaic RASopathies
Sign Up to like & getrecommendations! Published in 2022 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms23074036
Abstract: Mosaic RASopathies are a molecularly heterogeneous group of (neuro)cutaneous syndromes with high phenotypical variability. Postzygotic variants in KRAS have been described in oculoectodermal syndrome (OES), encephalocraniocutaneous lipomatosis (ECCL) and epidermal nevus syndrome (ENS). This study… read more here.
Keywords: kras variants; epidermal nevus; isolated epidermal; mosaic rasopathies ... See more keywords